Seoul, South Korea

Jin Keon Pai


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jin Keon Pai - Innovator in Oncology Therapeutics

Introduction

Jin Keon Pai is a notable inventor based in Seoul, South Korea, recognized for his pioneering work in the field of pharmaceutical chemistry. His innovative contributions focus on the development of therapeutic agents targeting cancer and related diseases. With a single patent to his name, Pai's work is rooted in the synthesis of novel compounds that hold promise for significant advancements in treatment strategies.

Latest Patents

Jin Keon Pai holds a patent for piperidinedione derivatives. This patent, titled "Piperidinedione derivatives," details a novel piperidinedione compound or a pharmaceutically acceptable salt thereof. The uses of this compound are particularly notable as they serve as anti-tumor agents or immunomodulators for treating CRBN protein-mediated diseases. Additionally, the compound can function as an E3 ligase binder in PROTAC compounds, which include a protein of interest ligand, a linker, and the E3 ligase binder. This innovative approach highlights the potential for developing targeted therapies using the described compounds and their derivatives.

Career Highlights

Currently, Jin Keon Pai is affiliated with Innocure Therapeutics, Inc., where he contributes his expertise to the development of advanced therapeutic solutions. His role at Innocure Therapeutics positions him at the forefront of oncology innovation, working to translate his patented discoveries into practical applications in patient care.

Collaborations

Throughout his career, Pai has worked alongside distinguished colleagues such as Hye-Dong Yoo and Young-jun Shin. These collaborations not only enhance the research outcomes but also contribute to developing a robust framework for advancing cancer treatment modalities.

Conclusion

Jin Keon Pai's contributions to the field of oncology through his novel piperidinedione derivatives exemplify the critical role of inventors in healthcare innovation. As he continues his work at Innocure Therapeutics, his pioneering spirit and collaborative efforts are likely to pave the way for groundbreaking therapies that can transform patient lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…